In the present work, analytical methods, UV Spectrophotometry and Liquid Chromatography (HPLC), were developed and validated for quantification of cefpirome, a broad-spectrum fourth-generation cephalosporin, in raw material and powder for injectable preparation. The UV spectrophotometric method was performed at 271 nm, using 0.1 M hydrochloric acid as solvent. The HPLC was carried out using Techsphere ODS column and mobile phase consisted of methanol-water (30:70, v/v) with flow rate 0.8 mL/min and UV detection at 265 nm. The validation method yielded good results demonstrated statistically that the methods were linear, precise, accurate, specific and robust. A preliminary stability study of cefpirome showed that the UV Spectrophotometry and Liquid Chromatography methods were specific for the determination cefpirome in the presence of its degradation products. No statistically difference was observed between the proposed methods. The UV Spectrophotometry and Liquid Chromatography methods allow the quantitation of cefpirome in pharmaceutical dosage form and raw material and can be used for the drug analysis in routine quality control.
Introduction
Cephalosporin is a group of broad-spectrum derived from species of fungi of the genus Cephalosporium and are related to the penicillins in both structure and mode of action but relatively penicillinase-resistant antibiotics. These antibiotics have low toxicity for the host, considering their broad antibacterial spectrum. They have the active nucleus of beta-lactam ring which results in a variety of antibacterial and pharmacologic characteristics when modified mainly by substitution at 3 and 7 positions. Their antibacterial activities result from the inhibition of mucopeptide synthesis in the cell wall. Traditionally, the cephalosporins are divided into first-, second-, third-, fourth and fifth-generation agents (Figure 1 ), is an injectable broad-spectrum aminothiazolyl cephalosporin, produced as sulfate salt. It is considered to be highly active against both gram-negative organisms including Pseudomonas aeruginosa and gram-positive organisms including staphylococci. It is stable to both plasmid and chromosomal β-lactamases and has been shown to induce less class I β-lactamase resistance than other cephalosporins (2, (5) (6) (7) . The increased spectrum of activity, together with high stability against -lactamases and rapid transmembrane transport, distinguishes cefpirome as an example of a fourthgeneration cephalosporin and its principal use is in treatment for patients' septic shock or several sepsis (2, (5) (6) (7) (8) (9) (10) . Methods have been reported for the determination of cefpirome in plasma, serum, urine, tissue, raw material and pharmaceutical form. These methods include microbiological assay, HPLC, voltammetry assay, UV spectrometry and pH potentiometry (2, (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . The aim of this study was to develop and validate simple and rapid UV Spectrophotometry and Liquid Chromatography (HPLC) methods for the quantification of cefpirome in raw material and powder for injectable preparation. These methods were validated according to the International Conference on Harmonization (ICH) guidelines (20) . quartz cells, optical path of 10 mm. The spectra were recorded using 1 mm slit and 120 nm.min-1 scanning speed. The assay was performed at analytical wavelength 271 nm (with ± 0.5 nm of wavelength accuracy) and 0.1 M hydrochloric acid (HCl) as solvent.
HPLC conditions
The Liquid chromatography system consisted of a Schimadzu SCL-10A, with SPD-M10A Diode Array Detector (set at 265 nm), a SCL-10A VP system controller, a LC 10 AD VP pump, a SIL-10AD auto injector syringe unit, a CTO-10AC VP Column Oven (set at 25 °C), Class-VP software (Shimadzu, Kyoto, Japan) and Techsphere® ODS RP-18 column (5 µm, 250 mm x 4.6 mm) (HPLC Technology -Welwyn Garden City, United Kingdom) fed with methanol-water (30:70, v/v) with flow rate 0.8 mL/min.
Reference and samples preparation
To UV spectrophotometry method, the reference and samples solutions were prepared using an amount of powder equivalent to 24 mg of cefpirome that was transferred to 100 mL volumetric flask with 0.1 M hydrochloric acid and followed by making up to final volume with this solvent (240 µg/mL). An aliquot of this solution (5 mL) was transferred to the 100 mL volumetric flask and made up to final volume with 0.1 M hydrochloric acid (12 µg/mL). To HPLC method, the reference and samples solutions were prepared using an amount of powder equivalent to 25 mg of cefpirome that was transferred to 100 mL volumetric flask with ultra-purified water and followed by making up to final volume with this solvent (250 µg/mL). An aliquot of this solution (4 mL) was transferred to the 100 mL volumetric flask and made up to final volume with ultra-purified water (10 µg/mL). In each assay, 20 µL of solution was used.
Methods validation
The methods were performed and validated by determination of the following operational characteristics: linearity, range, precision, accuracy, specificity, limit of detection, limit of quantitation and robustness.
Linearity
The linearity of the methods were determined using cefpirome standard at different concentrations levels. Three calibration curves were prepared by day, for three consecutives days. The slopes and the statistical analysis of the calibration curves were calculated by linear regression. To UV spectrophotometry method, after choose the best solvent and wavelength, Ringbom's curve was prepared using range concentration of cefpirome between 2.0 to 40.0 µg/mL, using 0.1 M hydrochloric acid as solvent, the calibration curves were obtained after an amount of powder equivalent to 20 mg of cefpirome has transferred to 500 mL volumetric flask with 0.1 M hydrochloric acid, followed by making up to final volume with this solvent (40 µg/mL). 
Precision
The precision of the assay was determined by repeatability (intra-assay) and intermediate precision (inter-assay). Repeatability was evaluated by assaying three samples at the same concentration and during the same day. The intermediate precision was certificated by comparing the assays on three different days. The precision is calculated by relative standard deviation (RSD) (20) (21) (22) .
Accuracy
The accuracy was determined by recovery, in which known amount of cefpirome reference substance was added to the samples at the beginning of the process. The recovery test was performed at three concentration levels. The percentage recovery of cefpirome reference added was calculated using the equation proposed by AOAC (22) . In UV spectrophotometry method, an amount of powder equivalent to 24 mg of cefpirome (sample) was transferred to 100 mL volumetric flask with 0.1 M hydrochloric acid and followed by making up to final volume with this solvent (240 µg/mL). An aliquot of this solution (5 mL) was transferred to the three 100 mL volumetric flask and aliquots of 5.0 mL, 10.0 and 15.0 mL of a 60 µg/mL of cefpirome reference substance were added in each volumetric flask and made up to final volume with 0.1 M hydrochloric acid (corresponding to 300, 600 and 900 µg, respectively). The solutions contending final concentrations of 15.0, 18.0 and 21.0 µg/mL of cefpirome were submitted to the UV spectrophotometric assay described above. Each solution was prepared in triplicate in two days. To the HPLC method, an amount of powder equivalent to 25 mg of cefpirome was transferred to 100 mL volumetric flask with ultra-purified water and followed by making up to final volume with this solvent (250 µg/mL). An aliquot of this solution (4 mL) was transferred to the three 100 mL volumetric flasks and aliquots of 5.0 mL, 7.5 and 10.0 mL of a 100 µg/mL of cefpirome reference substance were added in each volumetric flask and made up to final volume with ultra-purified water (corresponding to 0.5, 0.75 and 1.0 mg, respectively) and made up to final volume with ultrapurified water. The solutions contending final concentrations of 15.0, 17.5 and 20.0 µg/mL of cefpirome were submitted to the chromatographic assay described above. Each solution was prepared in triplicate and injected three times in two days.
Specificity
The specificity was determined by measurement in presence of degradation products. Commercially obtained samples were diluted in injectable water at a concentration of 100 mg/mL of cefpirome were submitted to accelerated degradation at 40 °C for twenty four hours, in climatic chamber with controlled humidity Nova Ética 420 LDC (Nova Ética, São Paulo, Brazil), for thermal stress, and solutions contending 0.6 mg/mL of cefpirome, for photodegradation studies using UV light (254 nm) for one hour, respectively. These solutions were then diluted with 0.1 M hydrochloric acid to obtain the theoretical concentration of 12 µg/mL for UV spectrophotometry method, and with ultra purifies water to obtain the theoretical concentration of 10 µg/mL, for HPLC method, and were assayed against freshly prepared solution of reference standard and sample at the same concentrations. Each sample was analyzed six times. In the case of UV spectrophotometry method, was verificated the influence of others cephalosporins. In the case of the HPLC method, also was determined the peak purity.
Detection limit
The detection limit was calculated based on the standard deviation of the response and the slope. Both estimated from the calibration curve of the cefpirome (20).
Quantitation limit
The quantitation limit was calculated based on the standard deviation of the response and the slope. Both estimated from the calibration curve of the cefpirome (20) .
Robustness
The evaluation of robustness was during the development phase and under study. In the case of UV spectrophotometry method, were studied the influence of concentration of solvent (0.08 and 0.12 M hydrochloric acids) and different equipment. In the case of HPLC method, were studied the influence of variations in mobile phase composition 
Analytical solution stability
The analytical solutions stability was determined by comparison of quantitation of components in solutions after storage conditions (depends on need) to freshly prepared standards. In this study, the solutions were kept at room temperature for 6 and 24 hours and stored refrigerated at 5 °C for 24 and 48 hours.
Results and Discussion
The validation of analytical procedures is an important part of the registration application for a new pharmaceutical preparation. Beyond the regulatory requirements, the performance and reliability of the control test procedure are essential to the quality control of drugs. Results which reflect the quality of the pharmaceutical to be tested may easily lead to drastic financial consequences. Therefore, validation should be regarded as part of an integrated concept to ensure the quality, safety and efficacy of pharmaceuticals (23, 24) . The elaboration of the methods described was begun by developing optimal conditions. Several conditions were investigated for each method and chosen optimal variants against common criteria critical in quantitative analysis, such as solvent, selectivity and linearity.
To choose the best wavelength and solvent to be used in UV spectrophotometry method, spectra were performed on UV-VIS spectrophotometer using ultra purified water, 0.1 M hydrochloric acid, ethanol and methanol. 0.1 M hydrochloric acid and the wavelength 271 nm were chosen the best experimental conditions (Figure 2 ). The linearity of an analytical method is its ability to elicit test results that are directly, or by a well-defined mathematical transformation, proportional to the concentration of analyte in samples within a given range (25) . Using the Ringbom's curve (Figure 3) , the calibration curves were performed and the results showed good linearity on the range of concentration of cefpirome between 2.0 to 22.0 µg/mL for the UV spectrophotometry method ( Figure  4 ). The calibration curves were constructed by plotting concentration versus absorbance and showed good linearity with excellent correlation coefficients (r). The representative linear equation for cefpirome was y = 0.0437x + 0.0027 (n = 9, r = 0.9994). There are no deviation from parallelism and linearity with results obtained (Fcalculated<Fcritical p = 0.01) as showed in Table 1 . 8.19x10
Each value is the mean of 6 assays.
For the development and validation of the method by HPLC, columns, solvents, different combinations and proportions of solvent, wavelength, flow, pH and temperatures were tested in order to obtain the best analytical conditions for quantification of cefpirome. The best system suitability was obtained when the Techsphere® ODS RP-18 column (5 µm, 250 mm x 4.6 mm), methanol-water (30:70, v/v) as mobile phase, flow rate at 0.8 mL/min and temperature at 25 °C were used. The retention time of cefpirome was about 6.9 min. as shown in Figure 5 .
In this HPLC method, the calibration curves were constructed by plotting concentration versus peak area and showed good linearity, on the range concentration of cefpirome between 2.0 to 20.0 µg/mL ( Figure 6 ), with excellent correlation coefficients (r). The representative linear equation for cefpirome was y = 4.6823x + 0.4555 (n = 6, r = 0.9996) There are no deviation from parallelism and linearity with results obtained (Fcalculated<Fcritical p = 0.01) as showed in Table 2 .
The detection limit (DL) is the lowest amount of analyte in a sample that can be detected, but not necessarily quantitated, under the stated experimental conditions. The quantitation limit (QL) is the lowest amount of analyte in a sample that can be determined with acceptable precision and accuracy under stated experimental conditions. The DL and QL are usually expressed as the concentration of analyte in the sample (19) (20) (21) (22) . Although some guidelines of validation on analytical procedures don't ask the calculation of DL and QL for the pharmaceutical product, these limits were determined in this study. In the case of the UV spectrophotometry method, the DL and QL were 0.19 and 0.62 µg/mL, respectably. In the case of HPLC method, the DL and QL were 0.09 and 0.27 µg/mL respectably. These results showed that the both methods were very sensible. The precision of the assay was determined by repeatability and intermediate precision which results were expressed as the relative standard deviation (RSD) of a series of measurements in the same day and on different days respectively. The precision of an analytical method is the degree of agreement among individual test results when the method is applied repeatedly to multiple samplings of a homogeneous sample (20) (21) (22) (23) . The repeatability was studied by determination of the samples in six assays, at the same concentration, during the same day under the same experimental conditions. The result obtained shows RSD of 0.47 and 0.99 to UV spectrophotometry and HPLC method, respectively, indicating good intra-assay precision. Interassay variability was calculated from assays on 3 days and shows RSD of 0.80 and 1.24 to UV spectrophotometry and HPLC method, respectively (Tables 3 and 4) . The accuracy was proved by recovery test that are experimental designs to determine the agreement between the values found of the analyte and the real value that analyses (20) (21) (22) (23) . The recovery test was performed with three different concentration was the mean recovery were found to be 98.41% of reference substance (UV spectrophotometry method) and 101.14% (HPLC method) (Tables 5 and 6 ). Specificity is defined as the ability to assess unequivocally the analyte in the presence of components that may be expected to be present, such as impurities, degradation products and matrix components (14) (15) (16) (17) . The specificity of the proposed methods was studied analysis of degraded samples (Figures 7 and 8) . In case of the HPLC method, also was verificated the peak purity. The results obtained demonstrate that a decrease occurred in the concentration of cefpirome under the conditions used. The results were expressed as a percentage of the drug remaining (Tables 7  and 8 ).
Cefpirome was very instable at 40 °C and exposed to UV light (254 nm). After the degradation treatment, the contents of the containers were diluted with the 0.1 M hydrochloric acid or ultra-purified water, for UV spectrophotometry and HPLC methods, respectively, and showed loss of concentration (Figures 7 and 8) .
The spectrophotometric and chromatographic assays described were specific for the determination of cefpirome in the presence of possible degradation products. Figure 9 shows the purity curve obtained in the determination of cefpirome by the proposed chromatographic method in the analysis of the aqueous solution of the pharmaceutical form exposed to thermal degradation at 40 °C stored for two days. The high purity value indicates that the chromatographic method has specificity against the likely degradation products. Robustness is defined as a measure of capability of the method to remain unaffected by small, but deliberate variations in method parameters. The Tables 7 and 8 shows that the solutions assayed in robustness test exhibited no concentration changes of cefpirome.
To generate reproducible and reliable results, the stability of sample solution, standards and reagents must be determined prior to initiating the method validation studies. It is often essential that solutions be stable enough to allow for delays.
Samples and standards should be tested over a time period and quantitation of components should be determined by comparison to freshly prepared standards. A stability criterion for assay methods is that sample and standard solutions be stable for under defined storage conditions. Acceptable stability is 2% change in standard or sample response, relative to freshly prepared standards (23) . The analytical solutions of cefpirome in 0.1 M hydrochloric acid (240 µg/mL) and water (reference -250 µg/mL), kept at refrigerated temperature (5 °C) and room temperature for 24 and 48 hours, exhibited no concentration changes of cefpirome changes (Tables 7 and 8 ). The methods were compared by Student's t-test and no significant difference between UV spectrophotometry and HPLC was observed (p =0.01).
The results obtained in these assays were very satisfactory. Performed validation proved that UV spectrophotometry and Liquid Chromatography are good methods for pharmaceutical analysis of cefpirome in raw material and powder for injection. 
Conclusions
The results indicated that the UV spectrophotometric and chromatographic assay hold linearity, precision, accuracy, specificity and robustness at concentration range from 6 to 22 mg/mL, UV spectrophotometry method, and from 2 to 20 mg/mL, HPLC method, being acceptable methods for the routine quality control of cefpirome in raw material and pharmaceutical preparation.
